Tower Research Capital (TRC)’s Vor Biopharma VOR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $3.72K | Sell |
2,295
-1,153
| -33% | -$1.87K | ﹤0.01% | 4442 |
|
|
2025
Q1 | $2.47K | Sell |
3,448
-153
| -4% | -$110 | ﹤0.01% | 4547 |
|
|
2024
Q4 | $4K | Sell |
3,601
-697
| -16% | -$774 | ﹤0.01% | 4542 |
|
|
2024
Q3 | $3.01K | Sell |
4,298
-11,312
| -72% | -$7.92K | ﹤0.01% | 4908 |
|
|
2024
Q2 | $15.6K | Buy |
15,610
+13,999
| +869% | +$14K | ﹤0.01% | 3900 |
|
|
2024
Q1 | $3.82K | Sell |
1,611
-3,704
| -70% | -$8.78K | ﹤0.01% | 4783 |
|
|
2023
Q4 | $12K | Sell |
5,315
-10,366
| -66% | -$23.3K | ﹤0.01% | 4088 |
|
|
2023
Q3 | $33.2K | Buy |
15,681
+13,581
| +647% | +$28.8K | ﹤0.01% | 2934 |
|
|
2023
Q2 | $6.49K | Buy |
+2,100
| New | +$6.49K | ﹤0.01% | 4674 |
|
|
2023
Q1 | – | Sell |
-25,881
| Closed | -$172K | – | 6315 |
|
|
2022
Q4 | $172K | Sell |
25,881
-20,779
| -45% | -$138K | 0.01% | 1408 |
|
|
2022
Q3 | $186K | Buy |
46,660
+25,148
| +117% | +$100K | ﹤0.01% | 2010 |
|
|
2022
Q2 | $107K | Sell |
21,512
-9,762
| -31% | -$48.6K | ﹤0.01% | 2234 |
|
|
2022
Q1 | $189K | Buy |
31,274
+12,824
| +70% | +$77.5K | ﹤0.01% | 1777 |
|
|
2021
Q4 | $215K | Buy |
18,450
+17,720
| +2,427% | +$206K | ﹤0.01% | 1714 |
|
|
2021
Q3 | $11K | Sell |
730
-202
| -22% | -$3.04K | ﹤0.01% | 4264 |
|
|
2021
Q2 | $17K | Buy |
932
+503
| +117% | +$9.18K | ﹤0.01% | 4055 |
|
|
2021
Q1 | $18K | Buy |
+429
| New | +$18K | ﹤0.01% | 3973 |
|